Doiron, R.C. et al. 2026. The sublingual vaccine MV140 is dominant over prophylactic antibiotics for the prevention of recurrent, uncomplicated urinary tract infections in adult women: A cost-utility analysis. Canadian Urological Association Journal. 20, 5 (Jan. 2026), E154–62. DOI:https://doi.org/10.5489/cuaj.9237.